Sponsor Pipeline

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05768529 Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Relapsed or Refractory Non-Hodgkin's Lymphoma Recruiting
NCT07036250 Clinical Study of U32 in Patients With Acute Myeloid Leukemia Acute Myeloid Leukaemia Recruiting
Phase 1
NCT06614686 U87 CAR-T in Patients With Advanced Head and Neck Tumors Nasopharynx Cancer Recruiting
NCT07093073 Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma B Cell Lymphoma Recruiting
Disease Areas
Head & Neck Cancer (1) Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free